Abstract: Aqueous crosslinkable coating composition suitable for anti-graffiti and heavy duty applications comprising: (A) an aqueous polymer emulsion comprising at least one vinyl fluoropolymer which comprises as a polymerized constituent monomer thereof (i) a fluoromonomer(s) having the formula (1) wherein R1 is CH3 or H, R2 is a per-fluorinated C1-5 alkyl group and n is 1, 2, 3 or 4, (ii) a hydroxyl functional monomer(s) and (iii) a carboxylic acid-functional monomer(s) where the vinyl fluoropolymer has a glass transition temperature Tg within the range of from ?50 to 90° C.

Abstract: A liquid non-aqueous dispersion including a silicone oil and a copolymer dispersed therein, the copolymer including (A) at least one radical polymerizable macromonomer containing dimethyl polysiloxane, and (B) at least one radical copolymerizable monomer with the macromonomer (A), which includes at least one (meth)acrylate monomer and optionally at least one vinyl monomer. This liquid non-aqueous dispersion has excellent water resistance, oil resistance and adhesive properties, and when used as a component of cosmetics, it can meet both requirements for long lasting make-up and good feeling of use of cosmetics.

Abstract: A coating for weatherstrips, windshield wipers, door seals, trunk seals, sunroof seals, windshield seals and the like. The coating comprises a water-based formula that provides high abrasion resistance and, optimally, also provides excellent weathering resistance. The abrasion resistance property is achieved via a combination of boron nitride and a high molecular weight silicone resin. Flexibility and weathering resistance are achieved via the addition of an acrylic/polyurethane/fluoropolymer resin binder blend and high UV-stabilizers and absorbers. Also provided is a method of manufacturing such coatings that comprises the steps of pre-dispersing the boron nitride in water and then combining the pre-dispersed boron nitride with the silicone resin and other ingredients.

Abstract: The present invention concerns a polymer composition comprising: a block copolymer (a) including a polymer block A, which is composed mainly of an ?-methylstyrene, and a hydrogenated or unhydrogenated polymer block B, which is composed of a conjugated diene or isobutylene and has a weight average molecular weight of 30,000 to 200,000; an acrylic resin (b); and a softener (c), wherein proportions (by mass) of the respective components in the polymer composition are such that each of the following relationships (1) and (2) holds: 0.05?Wb/Wa?2 and??(1) Wc/(Wa+Wb+Wc)?0.5??(2) wherein Wa, Wb, and Wc represent amounts (by mass) of the block copolymer (a), the acrylic resin (b) and the softener (c), respectively.

Abstract: Compositions of high and low performance elastomer are formed using a process that chemically reacts some of the high and low performance elastomers together to form a graft copolymer. The elastomeric compositions provide intimately mixed elastomeric compositions which are thermodynamically stable and do not phase separate. The elastomeric compositions exhibit a variety of improved properties compared to simple blends of the same high and low performance elastomers in the same weight proportions. The elastomeric compositions are useful for producing films, fabrics, and laminates for use in a wide variety of personal care and medical articles.

Abstract: This invention is related to multi-layer golf balls having an inner cover layer comprising a blend of styrene-block copolymer and trans-polyisoprene, an outer cover layer comprising a polyurethane, a polyurea or a mixture thereof, and a core comprising of thermosetting or thermoplastic materials.

Abstract: There is provided a thermosetting powder coating composition comprising (A1) a fluorine-containing copolymer and (B) a curing agent, in which the copolymer contains, as essential structural units, a fluoroolefin unit, an alkene unit and cyclohexyl vinyl ether unit and/or p-tertiary butyl vinyl benzoate unit, has a sum of cyclohexyl vinyl ether unit and p-tertiary butyl vinyl benzoate unit of from 5 to 45% by mole, has a thermal transition temperature of from 45° to 120° C. and has a crosslinkable reaction group. The thermosetting powder coating composition is excellent in storage stability and provides a coating film possessing a smooth surface and enhanced impact resistance.

Abstract: A vulcanized rubbery polymer composition comprising a component (A) and a thermoplastic resin (B), wherein the component (A) comprises a hydrogenated copolymer (A-1), which is obtained by hydrogenating a copolymer comprising a conjugated diene monomer unit and an aromatic vinyl monomer unit and having an aromatic vinyl monomer content of not less than 5% by weight and not more than 90% by weight, and which has a crystallization peak calorie measured by a differential scan calorimetry of not more than 2 J/g, and at least one vulcanizable rubber (A-2) selected from the group consisting of a copolymer (a1) comprising an ethylene unit and an ?-olefin unit of 3 to 20 carbon atoms and a hydrogenated rubber (a2) obtained from a homopolymer rubber of at least one conjugated diene monomer or a copolymer rubber comprising a conjugated diene monomer unit and an aromatic vinyl monomer unit and having an aromatic vinyl monomer content of less than 5% by weight.

Abstract: Hetero phase polymer compositions are described. The compositions may have polypropylene component, a modifier component and a compatibilizer component. The modifier component may in some embodiments be an ethylene ?-olefin copolymer with a density ?0.905 g/cm3. In other embodiments the modifier component may be a blend of a copolymer with a density of ?0.905 g/cm3, and an ethylene ?-olefin copolymer of lower, more traditional density.

Abstract: A homogeneous blend of a low density polyethylene with a metallocene-catalysed polyethylene having a density of from 0.906 g/cm3 and a Dow Rheology Index of at least 5/MI2,MI2 being the melt index measured according to ASTMD-1238 condition 190° C./2.16 kg and the Dow Rheology Index being determined by a dynamic rheological analysis performed at 190°.

Abstract: The present invention provides a method for preparing a copolymer useful for the manufacture of tires by coupling the ends of a living polymer obtained from copolymerization of a diene monomer and a vinyl aromatic monomer in the presence of an organolithium catalyst and a hydrocarbon solvent with a multi-reactive polysiloxane compound and then modifying the remaining uncoupled ends of the polymer with an amine compound. The use of the copolymer thus obtained for the fabrication of tires improves the affinity to silica as well as carbon black used as a reinforcing material and provides enhanced properties required for tires, such as increased wet traction, reduced rolling resistance, and increased tread wear.

Abstract: A bifunctional phenylene ether oligomer of the formula (1), obtained by oxidation polymerization of a bivalent phenol of the formula (2) and a monovalent phenol of the formula (3), wherein —X— is represented by the formula (2?), and Y—O— is represented by the formula (3), R2, R3, R4, R8, R9, R10 and R11 in the formula (2?) and the formula (3?) being required not to be a hydrogen atom, and its use.

Abstract: A no flow fluxing underfill having a hardener component comprising a phenolic component and an anhydride component in a molar ratio of phenolic component to anhydride component of between about 0.1:1 and about 2:1; or between about 0.8:1 and about 1.2:1. An underfill preparation method involving blending an epoxy component and a phenolic component, heating the blend, and cooling the blend, prior to incorporation of an anhydride component.

Abstract: The present invention provides network polymers obtained by curing compositions that comprise an ester with at least two terminal epoxy groups. Preferred esters include those represented by the formula (1), wherein each R1 independently represents a substituted or unsubstituted homoaliphatic or heteroaliphatic group; A represents a substituted or unsubstituted homoalkylene, hetemalkylene, arylene, or heteroarylene segment; and n represents an integer equal to or greater than 2.

Abstract: The present invention relates to a method for preparing polymers by gas-phase deposition polymerization, initiated by a zero valent metal and an initiator.

Abstract: A solid cocatalyst for olefin polymerization in which an ion-containing compound comprising a cation expressed by [R4M]+, wherein the group R are each individually selected from the group consisting of hydrogen atom and a substituted or non-substituted hydrocarbon group having from 1 to 30 carbon atoms with the exception of an aryl group; two or more groups R may form a ring by bonding with one another; at least one of the groups R is a hydrocarbon group having from 1 to 30 carbon atoms with the exception of an aryl group; and M represents nitrogen or sulfur, and a non-coordinating anion expressed by [A] said ion-containing compound is chemically bonded to a fine particulate carrier is used.

Abstract: This invention relates to a transition metal compound represented by the formula LMX wherein M is a Group 3 to 11 metal L is a bulky bidentate or tridentate neutral ligand that is bonded to M by two or three heteroatoms and at least one heteroatom is nitrogen; X is a substituted or unsubstituted catecholate ligand provided that the substituted catecholate ligand does not contain a 1,2-diketone functionality.

Abstract: The invention concerns a method for preparing a first generation polymer comprising a step which consists in free radical polymerization of a composition comprising: at least an ethylenically unsaturated monomer, a source of free radicals, at least a dithiophosphoroester compound.

Abstract: Biocompatible polymers useful for making anterior chamber intraocular lenses (AC-IOL) are provided. The biocompatible polymers are generally composed of one or more acrylate monomers, crosslinked with at least one diacrylate ester and may include one or more additional components such as ultraviolet light and/or blue-violet light absorbing dyes. The AC-IOLs made using the biocompatible polymers disclosed herein are suitable for placement in phakic or aphakic eyes and are intended for refractive correction including myopia, hyperopia, presbyopia and astigmatisms.

Abstract: Melt-fabricable, tough copolymer of tetrafluoroethylene and fluorinated vinyl ether is produced in a suspension polymerization process by copolymerizing tetrafluoroethylene and fluorinated vinyl ether in a pressurized, agitated reaction vessel which contains aqueous medium, free radical initiator, and a telogen, the aqueous medium being essentially free of fluorine containing organic solvent. The contents of the reaction vessel are agitated during polymerization sufficiently to coagulate copolymer of tetrafluoroethylene and fluorinated vinyl ether. The melt-fabricable, tough copolymer having a melt viscosity of less than about 1×106 Pa·S is isolated directly from the reaction vessel.

Abstract: Fluoroalkyl amidoalkyl alcohols of the formula are disclosed and their corresponding (meth)acrylate esters. These fluoroalkyl amidoalkyl (meth)acrylate monomers can be copolymerized with a wide variety of conventional ethylenically unsaturated monomers. The resulting copolymers are useful as water, oil- and grease-proofing agents for paper, textiles and hard surfaces such as masonry and wood.

Abstract: This invention relates to wettable biomedical devices comprising amphiphilic block copolymers. The amphiphilic block copolymers are useful as internal wetting agents for biomedical applications, such as implantable devices, ophthalmic devices and in one embodiment, contact lenses.

Abstract: A polymer includes repetitive units derived from a monomer compound according to formula (I): wherein R1 is a hydrogen atom, a methyl group or an ethyl group, A, which is identical or different, is a group comprising an ester group of formula -A1-C(O)—O-A2-, or an amide group of formula -A1-C(O)—NR10-A2-, wherein: R10, which is identical or different, is hydrogen or an alkyl, hydroxyalkyl, or aminoalkyl C1-C6 linear or branched group, A1, which is identical or different is a covalent bond or a group of formula —(CH2)p1— wherein p1 is an integer of from 1 to 6, A2, which is identical or different, is a linear or branched hydrocarbon group comprising optionally N, O, or S heteroatoms or heterogroups, optionally substituted, optionally forming or comprising a cycle, R1, R2, R3, R5 and R6, which are identical or different, are hydrogen, alkyl, hydroxyalkyl, or aminoalkyl C1-C6 linear or branched groups, or, if inside the brackets, form a heterocycle with group A2, m is an integer of from 1 to 10, n is an inte

Abstract: By using a high molecular weight syrup phase comprising PMMA or PMMI, it is possible to distribute fillers in the polymerization batch so that the distribution of the fillers remains homogeneous during the polymerization. A homogeneous foam results.

Abstract: Disclosed is a novel high 1,4-cis polybutadiene-polyurethane copolymer and a preparation method thereof. The present invention provides a high 1,4-cis polybutadiene-polyurethane copolymer represented by the following formula 1 and having an average molecular weight of at least 100,000, and a method for preparing the high 1,4-cis polybutadiene-polyurethane copolymer that includes polymerizing 1,3-butadiene or butadiene derivatives with a catalyst comprising a rare earth compound, a halogen-containing compound and an organoaluminum compound in the presence of a non-polar solvent, to prepare a polybutadiene having a high 1,4-cis content of at least 95%; and then introducing a polyurethane group to the polybutadiene.

Abstract: The present invention relates to dimethicone copolyol sulfosuccinates that contain alkyl groups having between 8 and 40 carbon atoms. More specifically, the invention relates to silicone-based sulfosuccinates that exhibit increased detergency while still maintaining mildness and foaming properties when used as surfactants in shampoos and other personal care products.

Abstract: A golf ball comprising a core, a cover encasing the core, at least one coating layer encasing the cover, and at least one indicia layer immediate adjacent to the coating layer is provided. At least one of the indicia and coating layers comprises at least one two-part, reactive composition comprising at least one radiation-curable iso(thio)cyanate and at least one isocyanate-reactive chemical.

Abstract: The invention concerns the field of manufacture of PET containers designed in particular for packaging food products, particularly bottles for aerated beverages such as in particular natural and mineral water. The method for manufacturing PET resin preforms and the resulting preforms, a method for making PET resin containers from the preforms and the manufactured containers, in particular food bottles made of PET resin. The method for making PET resin preforms is characterised in that it consists in using a PET resin having an intrinsic viscosity (IV) less than 0.65 dl/g.

Abstract: A process for purifying a crude polyether, comprising contacting a crude polyether obtained by addition polymerizing an active hydrogen-containing compound with an alkylene oxide compound in the presence of an alkali metal-containing basic catalyst to an adsorbent comprising a synthesized hydrous magnesium silicate compound which satisfies the following requirements (1) to (5) in order to reduce the alkali metal content of the crude polyether: (1) it is represented by the following formula I: (CaO)x.(MgO)y.(Al2O3)z.SiO2.mH2OI wherein x, y, z and m satisfy the following ranges: x<y, z<y, 0?x?0.1, 0.6?y?0.6, 0?z?0.1 and 0.1?m?1.5, (2) it is amorphous according to the analysis of its powder method X-ray diffraction diagram, (3) it has a BET specific surface area of 100 to 400 m2/g, (4) it has an alkali metal content of 0.1 wt % or less, and (5) it has an average particle diameter of 2 to 60 ?m.

Abstract: Disclosed herein are novel polypeptides and the nucleic acid sequences that encode them. Also disclosed are antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. Vectors, host cells, antibodies and recombinant methods for producing the polypeptides and polynucleotides, as well as methods for using same are also included. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of apoptosis associated disorders involving these novel human nucleic acids and proteins.

Abstract: Synthetic methods and compounds involving amino amides, peptides and peptidomimetics. Amino amide derivatives are prepared via the one-step three-component reaction of a glyoxamide, an amine, and an organoboron derivative. Conversion of the product to another glyoxamide intermediate allows the iterative use of this chemistry for the synthesis of peptides and peptidomimetics.

Abstract: This invention provides reagents and methods for delivering insulin, insulinomimetic agents, and the like to a vertebrate eye via subconjunctival routes, sub-Tenon's routes, or intravitreal routes for treatment of nerve-related vision disorders such as diabetic retinopathy, and formulations useful in the practice of the disclosed methods.

Abstract: Methods for the detection, monitoring and treatment of malignancies in which the HER-2/neu oncogene is associated are disclosed. Detection of specific T cell activation (e.g., by measuring the proliferation of T cells) in response to in vitro exposure to the HER-2/neu protein, or detection of immunocomplexes formed between the HER-2/neu protein and antibodies in body fluid, allows the diagnosis of the presence of a malignancy in which the HER-2/neu oncogene is associated. The present invention also discloses methods and compositions, including peptides, for treating such malignancies.

Abstract: Fusion proteins of protease inhibitors are provided, in particular fusion proteins of alpha 1-antitrypsin (AAT) and a second protease inhibitor, such as secretory leukocyte protease inhibitor (SLPI) or tissue inhibitor of metalloproteases (TIMP). Polynucleotides encoding the fusion proteins, vectors comprising such polynucleotides, and host cells containing such vectors are also provided. Methods of making the fusion proteins of the invention are also provide, as well as methods of using the fusion proteins, for example to inhibit protease activity in a biological sample or in the treatment of an individual suffering from, or at risk for, a disease or disorder involving unwanted protease activity.

Abstract: The present invention provides proteins having the Na+/glucose transporter activity, DNAs encoding the proteins, a method of screening for a compound enhancing or inhibiting the activity of the proteins, and compounds obtained by the screening method. The proteins having the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, 15 or 26 are useful as a diagnostic marker for a disease such as diabetes. The compounds enhancing or inhibiting the activity of the proteins, obtained the screening method using the proteins, can be used as a prophylactic and/or therapeutic agent for a disease such as diabetes and hyperlipidemia.

Abstract: The invention relates ton novel methods for measuring ion channel transmission and methods and compositions useful in the indentification of ligand gated channel agonists and modulators.

Abstract: A Factor VIII composition formulated without albumin, comprising the following formulation excipients in addition to Factor VIII: 4% to 10% of a bulking agent selected from the group consisting of mannitol, glycine and alanine; 1% to 4% of a stabilizing agent selected from the group consisting of sucrose, trehalose, raffinose, and arginine; 1 mM to 5 mM calcium salt; 100 mM to 300 mM NaCl; and a buffering agent for maintaining a pH of approximately between 6 and 8. Alternatively, the formulation can comprise 2% to 6% hydroxyethyl starch; 1% to 4% of a stabilizing agent selected from the group consisting of sucrose, trehalose, raffinose, and arginine; 1 mM to 5 mM calcium salt; 100 mM to 300 mM NaCl; and a buffering agent for maintaining a pH of approximately between 6 and 8.

Abstract: The invention provides vitamin K-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.

Abstract: The present invention relates to new genes encoding for the production of novel proteins involved in generation of reactive oxygen intermediates that affect cell division. The present invention also provides vectors containing these genes, cells transfected with these vectors, antibodies raised against these novel proteins, kits for detection, localization and measurement of these genes and proteins, and methods to determine the activity of drugs to affect the activity of the proteins of the present invention.

Abstract: The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Abstract: Novel anti-IL-23p40 specific human Ig derived proteins, including, without limitation, antibodies, fusion proteins, and mimetibodies, isolated nucleic acids that encode the anti-IL-23p40 Ig derived proteins, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, are useful for therapeutic compositions, methods and devices. Preferably, the anti-IL-23p40 specific human Ig derived proteins do not bind the p40 subunit of IL-12 and, thus, do not neutralize IL-12-related activity.

Abstract: The present invention provides a kind of HBV-antigen bound to heat shock proteins (hsps) which comprises core antigen, surface antigen and polymerase antigen. The present invention also provides a complex of HBV antigen bound to heat shock protein gp96 and hsp78, as well as a method for preparing the complex. The complex includes a complex of gp96 and hsp78 non-covalently bound to antigenic polypeptide, as well as a fusion protein of both which results from covalent binding. Such complex can be used to prepare therapeutic vaccine for treating hepatitis B and primary hepatocellular carcinoma.

Abstract: The present disclosure relates to symmetrical cationic diazo compounds of formula (I), the resonance forms, and also the acid addition salts and/or the solvates thereof: The present disclosure further relates to dyeing compositions comprising such compounds as a direct dye in a medium appropriate for the dyeing of keratin fibers, and also to a method of coloring keratin fibers that employs this composition, and a multi-compartment kit containing such compositions.

Abstract: This invention is in the area of regulatory DNA sequences and their methods of use. Specifically, DNA sequences found in the regulatory region of cytoprotective genes are described that are termed cytoprotective response elements. DNA constructs also are provided that include cytoprotective response elements operably linked to heterologous protein coding sequence, as well as cells and non-human organisms that include the cytoprotective response elements optionally operably linked to a heterologous protein coding sequence, and a method for screening for a compound that increases mRNA or protein regulated by a cytoprotective response element. It has been discovered that the cytoprotective response elements mediate the coordinate activation of certain genes that protect cells from damaging effects of oxidative stress, and that they do so, for example during conditions of hemodynamic shear stress.

Abstract: The present invention provides a protein having an A chain of a ricin-like toxin, a B chain of a ricin-like toxin and a heterologous linker amino acid sequence, linking the A and B chains. The linker sequence contains a cleavage recognition site for a disease specific protease such as a cancer, inflammatory, fungal, viral or parasitic protease. The invention also relates to a nucleic acid molecule encoding the protein and to expression vectors incorporating the nucleic acid molecule. In addition, the invention relates to a method for producing the recombinant protein in yeast, to nucleic acid molecules for use in yeast and to yeast transformed with such nucleic acid molecules.

Abstract: An isolated, purified or recombinant nucleic acid sequence is disclosed, comprising: (a) a sequence that encodes both an angiogenic factor antagonist and a vascular endothelial structure regulator; (b) a sequence substantially homologous to or that hybridizes to sequence (a) under stringent conditions; or (c) a sequence substantially homologous to or that hybridizes under stringent conditions to the sequence (a) or (b) but for the degeneracy of the genetic code; or (g) an oligonucleotide specific for any of the sequences (a), (b) or (c). Particular oligonucleotides (d) are those encoding the vascular endothelial structure regulator. Also described are methods for preparing the recombinant polynucleotide, proteins encoded by such polynucleotides and their use in gene or protein therapy for the treatment of conditions such as cancer.

Abstract: The present invention provides novel polynucleotides encoding LSI-01 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel LSI-01 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

Abstract: The subject invention pertains to antibodies that have binding specificity for an antigen that is expressed on a subset of human, hematopoietic mononuclear cells, including a hematopoietic stem cell population, but is not expressed on normal, mature myeloid cells. In one embodiment, a monoclonal antibody, MG1, is provided. This antibody is useful in methods of isolating cell suspensions from human blood and marrow that can be employed in bone marrow transplantation, genetic therapy, and in treating other diseases of the hematopoietic system. Cell suspensions containing MG1+ human hematopoietic cells are also provided, as well as therapeutic methods employing the cell suspensions. The subject invention also pertains to the novel antigen recognized by the subject antibodies.

Abstract: Oligonucleotide primers and polynucleotide probes provide selective amplification and detection of Id genetic sequences and are selected both (1) to provide the desired specificity so that they amplify only the specific Id type to which they are targeted; and (2) to introduce terminal restriction endonuclease cleavage sites into the amplicon that facilitate the incorporation of the amplicon into plasmid-based vectors. Detection of Id genetic sequences can be carried out using the labeled-amplicon by reamplifying the amplicon with the primers in the presence of labeled, for example radiolabeled, deoxynucleotide triphosphates. The probes of the invention correspond in sequence to the amplicons produced using the primers of the invention, after cleavage at the restriction endonuclease sites.

Abstract: A process for the phosphitylation of an alcohol or thiol with a phosphitylation agent in the presence of an activator is provided. The activator has the formula: wherein p is 0 or an integer from 1 to 4 and R for each occurrence is a substituent. Preferably X7 is O and p is 0. The activator is commonly employed as a salt complex with an organic base. Preferred alcohols or thiols include nucleosides and oligonucleotides. The process is particularly suited for the synthesis of phosphoramidites.